{"title":"Glyxambi","description":null,"products":[{"product_id":"glyxambi-10mg-5mg-tablet-empagliflozin-and-linagliptin","title":"Glyxambi 10mg\/5mg Tablet (Empagliflozin and Linagliptin )","description":"\u003cp\u003e\u003cstrong\u003eGlyxambi Medicine Description\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDrug Class:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eAntidiabetic Combination Drug\u003c\/li\u003e\r\n\u003cli\u003eSodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor \u0026amp; Dipeptidyl Peptidase-4 (DPP-4) Inhibitor\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eCategories:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eOral Hypoglycemics\u003c\/li\u003e\r\n\u003cli\u003eType 2 Diabetes Medications\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eActive Ingredient Name:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eEmpagliflozin (SGLT2 Inhibitor)\u003c\/li\u003e\r\n\u003cli\u003eLinagliptin (DPP-4 Inhibitor)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003ePopular and Other Names:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eGlyxambi\u003c\/strong\u003e (brand name)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eEmpagliflozin\/Linagliptin\u003c\/strong\u003e (generic name)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eJardiance\u003c\/strong\u003e (Empagliflozin alone)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eTradjenta\u003c\/strong\u003e (Linagliptin alone)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eMode of Action\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cp\u003eGlyxambi is a combination of two oral medications that work together to help control blood sugar levels in individuals with type 2 diabetes. \u003cstrong\u003eEmpagliflozin\u003c\/strong\u003e blocks the reabsorption of glucose in the kidneys, allowing excess glucose to be excreted in urine, while \u003cstrong\u003eLinagliptin\u003c\/strong\u003e enhances the body's natural ability to regulate glucose by inhibiting the DPP-4 enzyme, thereby increasing incretin levels that promote insulin release. Together, these mechanisms help maintain healthy blood sugar levels, reducing the risk of complications associated with diabetes.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eHow to Use Glyxambi\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e\u003cbr\u003eGlyxambi is typically taken once daily in the morning, with or without food. Swallow the tablet whole, do not crush, chew, or break it.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eFrequency:\u003c\/strong\u003e\u003cbr\u003eTake Glyxambi consistently every day to maximize blood sugar control. If you miss a dose, take it as soon as possible, but skip the missed dose if it’s near your next dose.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eRecommended Dosage\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eInitial Dose:\u003c\/strong\u003e\u003cbr\u003eThe recommended starting dose is 10 mg Empagliflozin\/5 mg Linagliptin once daily.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eMaximum Dose:\u003c\/strong\u003e\u003cbr\u003eThe dose may be increased to 25 mg Empagliflozin\/5 mg Linagliptin, depending on blood sugar control and doctor recommendations.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eMissed Dose:\u003c\/strong\u003e\u003cbr\u003eIf a dose is missed, take it as soon as you remember. If it is near the time for the next dose, skip the missed dose and resume your regular dosing schedule.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eDirections\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHydration:\u003c\/strong\u003e\u003cbr\u003eDrink plenty of water while taking Glyxambi to avoid dehydration, as Empagliflozin increases glucose excretion in urine.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eDiet and Exercise:\u003c\/strong\u003e\u003cbr\u003eFollow a balanced diet and engage in regular physical activity alongside Glyxambi treatment for optimal diabetes management.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003cbr\u003eStore Glyxambi at room temperature, away from direct sunlight and moisture.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eCautions\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eKidney Function:\u003c\/strong\u003e\u003cbr\u003eGlyxambi is not recommended for patients with severe kidney impairment, as Empagliflozin may not be effective and can increase the risk of side effects.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eDehydration Risk:\u003c\/strong\u003e\u003cbr\u003eSince Glyxambi promotes excess glucose excretion through urine, it may increase the risk of dehydration. Drink plenty of fluids.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHypoglycemia Risk:\u003c\/strong\u003e\u003cbr\u003eWhen combined with insulin or sulfonylureas, there is a risk of hypoglycemia (low blood sugar). Monitor blood sugar levels regularly.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003ePregnancy \u0026amp; Breastfeeding:\u003c\/strong\u003e\u003cbr\u003eGlyxambi should not be used during pregnancy or breastfeeding unless prescribed by a doctor, as it may affect the baby.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eManaging Side Effects\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eIncreased urination\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDehydration\u003c\/strong\u003e (thirst, dry mouth)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eNasopharyngitis\u003c\/strong\u003e (common cold)\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eUrinary tract infections\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eManagement:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eDrink plenty of water to stay hydrated.\u003c\/li\u003e\r\n\u003cli\u003eReport signs of urinary tract infection (painful urination, fever) to your healthcare provider promptly.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eKetoacidosis\u003c\/strong\u003e (symptoms include difficulty breathing, nausea, vomiting)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eSevere allergic reactions\u003c\/strong\u003e (rash, swelling, difficulty breathing)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eAction:\u003c\/strong\u003e\u003cbr\u003eSeek immediate medical attention if you experience symptoms of ketoacidosis or severe allergic reactions.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eGuidelines\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eRegular Monitoring:\u003c\/strong\u003e\u003cbr\u003eMonitor your blood sugar levels regularly and keep your healthcare provider informed of any changes in your blood sugar control.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eKidney Function Monitoring:\u003c\/strong\u003e\u003cbr\u003eYour doctor may perform regular kidney function tests to ensure the safe use of Glyxambi.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWeight Loss:\u003c\/strong\u003e\u003cbr\u003eSome patients may experience weight loss due to the mechanism of Empagliflozin. This can be a benefit for some individuals but should be monitored.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cstrong\u003eFrequently Asked Questions (FAQs)\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat is Glyxambi used for?\u003c\/strong\u003e\u003cbr\u003eGlyxambi is prescribed to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan Glyxambi cause low blood sugar?\u003c\/strong\u003e\u003cbr\u003eGlyxambi alone has a low risk of causing low blood sugar (hypoglycemia). However, the risk increases when combined with insulin or other antidiabetic drugs.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eIs Glyxambi safe for patients with kidney disease?\u003c\/strong\u003e\u003cbr\u003eGlyxambi is not recommended for patients with severe kidney impairment. Your doctor will assess your kidney function before prescribing it.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow does Glyxambi help with diabetes?\u003c\/strong\u003e\u003cbr\u003eGlyxambi helps control blood sugar levels by preventing glucose reabsorption in the kidneys and enhancing insulin production, which lowers blood glucose.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan I take Glyxambi with other diabetes medications?\u003c\/strong\u003e\u003cbr\u003eYes, Glyxambi can be taken with other diabetes medications like insulin or sulfonylureas, but careful monitoring of blood sugar levels is essential.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Glyxambi?\u003c\/strong\u003e\u003cbr\u003eIf you miss a dose, take it as soon as you remember unless it’s close to the time of your next dose. Never double the dose.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan Glyxambi cause dehydration?\u003c\/strong\u003e\u003cbr\u003eYes, because it promotes glucose excretion through urine, Glyxambi may increase the risk of dehydration. Drink plenty of fluids to stay hydrated.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"Magento","offers":[{"title":"Default Title","offer_id":49209693339894,"sku":"Glyxambi (Empagliflozin and Linagliptin) 10mg\/5mg 30 Tablets","price":82.68,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/1855\/0006\/files\/glyxambi-ezgif.com-webp-to-png-converter.png?v=1760859181"},{"product_id":"glyxambi-25-5mg-empagliflozin-and-linagliptin","title":"Glyxambi 25\/5mg (Empagliflozin and Linagliptin )","description":"\u003cp\u003e\u003cstrong\u003eGlyxambi (Empagliflozin + Linagliptin): Comprehensive Guide\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003ch3\u003eWhat is Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eGlyxambi\u003c\/strong\u003e is an oral combination medication used for the management of \u003cstrong\u003eType 2 diabetes mellitus\u003c\/strong\u003e. It contains two active ingredients that work synergistically to improve glycemic control:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eEmpagliflozin\u003c\/strong\u003e – a member of the \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eSGLT2 (Sodium-Glucose Co-Transporter-2) inhibitors\u003c\/a\u003e\u003c\/strong\u003e class that reduces blood sugar by preventing renal glucose reabsorption and increasing urinary glucose excretion.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eLinagliptin\u003c\/strong\u003e – a \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eDPP-4 (Dipeptidyl Peptidase-4) inhibitor\u003c\/a\u003e\u003c\/strong\u003e that enhances the body's incretin system, leading to increased insulin secretion and decreased glucagon production in a glucose-dependent manner.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eManufactured by \u003cstrong\u003eBoehringer Ingelheim\u003c\/strong\u003e and \u003cstrong\u003eEli Lilly and Company\u003c\/strong\u003e, Glyxambi is \u003cstrong\u003eClinically Approved Pharmaceuticals\u003c\/strong\u003e and is indicated for patients who need improved glycemic control beyond what is achieved with diet and exercise alone.\u003c\/p\u003e\r\n\u003cp\u003e\u003cem\u003eReferences: \u003ca target=\"_new\" rel=\"noopener\"\u003eFDA Glyxambi Prescribing Information\u003c\/a\u003e, \u003ca target=\"_new\" rel=\"noopener\"\u003eDrugs.com: Empagliflozin\u003c\/a\u003e, \u003ca target=\"_new\" rel=\"noopener\"\u003eDrugs.com: Linagliptin\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the benefits of Glyxambi for managing Type 2 Diabetes?\u003c\/h3\u003e\r\n\u003ch4\u003e1. \u003cstrong\u003eEnhanced Glycemic Control\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eClinical studies have demonstrated that Glyxambi significantly reduces \u003cstrong\u003eHbA1c levels\u003c\/strong\u003e compared to monotherapy. The dual mechanism of action helps patients achieve better glycemic control by addressing hyperglycemia from both renal and pancreatic pathways.\u003cbr\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003eClinical Trial Data on SGLT2 and DPP-4 Inhibitors\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003ch4\u003e2. \u003cstrong\u003eDual Mechanism of Action\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eBy combining an \u003cstrong\u003eSGLT2 inhibitor\u003c\/strong\u003e with a \u003cstrong\u003eDPP-4 inhibitor\u003c\/strong\u003e, Glyxambi targets different aspects of diabetes pathophysiology:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eEmpagliflozin\u003c\/strong\u003e lowers blood glucose by promoting its excretion.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eLinagliptin\u003c\/strong\u003e enhances endogenous incretin activity, improving insulin secretion and reducing glucagon levels.\u003cbr\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003eMechanism of Action - PubMed\u003c\/a\u003e\u003c\/em\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e3. \u003cstrong\u003eWeight Management\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eEmpagliflozin is associated with \u003cstrong\u003emodest weight loss\u003c\/strong\u003e due to caloric loss via glycosuria, while linagliptin is generally weight neutral. This combination is particularly beneficial for overweight individuals with Type 2 diabetes.\u003c\/p\u003e\r\n\u003ch4\u003e4. \u003cstrong\u003eCardiovascular and Renal Benefits\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eEmpagliflozin has shown to reduce cardiovascular mortality and slow the progression of renal disease, as evidenced in the landmark \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eEMPA-REG OUTCOME trial\u003c\/a\u003e\u003c\/strong\u003e. These benefits extend to patients using Glyxambi, making it a valuable option for those at risk for heart and kidney complications.\u003c\/p\u003e\r\n\u003ch4\u003e5. \u003cstrong\u003eConvenience and Improved Compliance\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eOffering the benefits of two therapies in a single, once-daily tablet simplifies the treatment regimen, which can lead to better patient adherence and improved overall outcomes.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the side effects of Glyxambi?\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eGenital Infections:\u003c\/strong\u003e Increased risk due to empagliflozin’s promotion of glycosuria.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eUrinary Tract Infections (UTIs):\u003c\/strong\u003e Symptoms may include burning during urination.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRespiratory Infections:\u003c\/strong\u003e Upper respiratory tract infections have been reported with linagliptin.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eHypoglycemia:\u003c\/strong\u003e Particularly when used alongside other glucose-lowering medications such as insulin or sulfonylureas.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003eRare but Serious Side Effects:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDiabetic Ketoacidosis (DKA):\u003c\/strong\u003e Although rare, there is a risk associated with SGLT2 inhibitors.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAcute Kidney Injury:\u003c\/strong\u003e Caution is advised in patients with pre-existing renal impairment.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePancreatitis:\u003c\/strong\u003e A potential risk with DPP-4 inhibitors, warranting prompt medical attention if suspected.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cem\u003eReference: \u003ca target=\"_new\" rel=\"noopener\"\u003eFDA Glyxambi Safety Information\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat should I know before taking Glyxambi?\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cstrong\u003e1. Contraindications and Precautions:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eNot for Type 1 Diabetes:\u003c\/strong\u003e Glyxambi is not indicated for patients with Type 1 diabetes or those with a history of diabetic ketoacidosis.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRenal Impairment:\u003c\/strong\u003e It is contraindicated in patients with severe renal impairment (as defined by specific eGFR thresholds) or those on dialysis.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePancreatitis History:\u003c\/strong\u003e Patients with a history of pancreatitis should exercise caution.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e2. Drug Interactions:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eConcomitant use with other \u003cstrong\u003eblood glucose-lowering agents\u003c\/strong\u003e (such as insulin or sulfonylureas) may increase the risk of hypoglycemia.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDrugs affecting renal function\u003c\/strong\u003e should be used with caution in patients taking Glyxambi.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e3. Pregnancy and Breastfeeding:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eGlyxambi is generally \u003cstrong\u003enot recommended during pregnancy or breastfeeding\u003c\/strong\u003e. Consult your healthcare provider for alternative therapies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e4. Monitoring:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eRegular monitoring of \u003cstrong\u003eblood glucose levels, renal function,\u003c\/strong\u003e and signs of infection is essential during treatment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/www.diabetes.org\/\" target=\"_new\" rel=\"noopener\"\u003eAmerican Diabetes Association Guidelines\u003c\/a\u003e, \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\"\u003eFDA Safety Alerts\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhy is Glyxambi prescribed?\u003c\/h3\u003e\r\n\u003cp\u003eGlyxambi is prescribed to:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eImprove Glycemic Control:\u003c\/strong\u003e As an adjunct to diet and exercise in adults with Type 2 diabetes inadequately controlled by monotherapy.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eReduce Cardiovascular and Renal Risks:\u003c\/strong\u003e The empagliflozin component offers proven benefits in reducing cardiovascular mortality and slowing kidney disease progression.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eSimplify Treatment Regimens:\u003c\/strong\u003e Combining two effective therapies into one tablet can enhance adherence and overall patient outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhy choose Glyxambi over other combination treatments?\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDual Action:\u003c\/strong\u003e The combination of an SGLT2 inhibitor (empagliflozin) and a DPP-4 inhibitor (linagliptin) provides a complementary approach to managing hyperglycemia.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRobust Clinical Evidence:\u003c\/strong\u003e Glyxambi’s components are supported by extensive clinical trials demonstrating significant improvements in \u003cstrong\u003eHbA1c\u003c\/strong\u003e, weight management, and cardiovascular outcomes.\u003cbr\u003e\u003cem\u003eReference: \u003ca target=\"_new\" rel=\"noopener\"\u003eEMPA-REG OUTCOME Trial\u003c\/a\u003e\u003c\/em\u003e\n\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eConvenience:\u003c\/strong\u003e A single tablet regimen reduces pill burden and can lead to improved medication adherence.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFavorable Safety Profile:\u003c\/strong\u003e When used as directed, Glyxambi offers an effective and well-tolerated option for many patients.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eHow does Glyxambi work in the body?\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eEmpagliflozin:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInhibits the \u003cstrong\u003eSGLT2 protein\u003c\/strong\u003e in the kidneys, preventing glucose reabsorption and promoting its excretion via urine, which leads to a reduction in blood sugar levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eLinagliptin:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInhibits \u003cstrong\u003eDPP-4\u003c\/strong\u003e, an enzyme that degrades incretin hormones. This results in prolonged incretin activity, enhancing insulin secretion and reducing glucagon levels in a glucose-dependent manner.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eTogether, these mechanisms provide a \u003cstrong\u003ecomprehensive approach\u003c\/strong\u003e to managing Type 2 diabetes by targeting both renal and pancreatic pathways.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eHow should Glyxambi be taken (with or without food)?\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Glyxambi is taken orally once daily, with or without food. Taking it with food may help reduce gastrointestinal discomfort related to linagliptin.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e Follow your healthcare provider’s instructions regarding dosage. The typical fixed-dose combinations are designed to simplify the regimen.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eTablet Integrity:\u003c\/strong\u003e Do not crush or split the tablet unless specifically advised by your healthcare provider.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the available doses of Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003eGlyxambi is available in fixed-dose combinations, typically including:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eEmpagliflozin 10mg \/ Linagliptin 5mg\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eEmpagliflozin 25mg \/ Linagliptin 5mg\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eThese formulations allow for tailored therapy based on the patient's glycemic control needs and overall health profile.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhere can I buy Glyxambi online safely?\u003c\/h3\u003e\r\n\u003cp\u003eTo ensure safety and authenticity, purchase \u003cstrong\u003eGlyxambi\u003c\/strong\u003e from reputable online pharmacies such as \u003ca href=\"https:\/\/www.waldrugmart.com\" target=\"_new\" rel=\"noopener\"\u003e\u003cstrong\u003eWaldrugmart\u003c\/strong\u003e\u003c\/a\u003e, which require a valid prescription, offer verified customer support, and provide secure shipping options.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhere can I learn more about Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003eFor additional information and detailed prescribing guidelines, consult the following trusted sources:\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.glyxambi.com\" target=\"_new\" rel=\"noopener\"\u003eOfficial Glyxambi Website\u003c\/a\u003e\u003c\/strong\u003e – Manufacturer’s information and patient resources.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\"\u003eFDA Medication Guide\u003c\/a\u003e\u003c\/strong\u003e – Regulatory-approved prescribing information.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.diabetes.org\/\" target=\"_new\" rel=\"noopener\"\u003eAmerican Diabetes Association (ADA)\u003c\/a\u003e\u003c\/strong\u003e – Educational resources on diabetes management.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003ePubMed\u003c\/a\u003e\u003c\/strong\u003e – For peer-reviewed clinical research articles.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eGlyxambi\u003c\/strong\u003e offers a powerful, dual-action approach to managing Type 2 diabetes by combining the benefits of empagliflozin and linagliptin in a single, convenient tablet. With robust clinical data supporting its efficacy in improving glycemic control and reducing cardiovascular and renal risks, Glyxambi is a compelling option for patients who require comprehensive diabetes management. As always, consult your healthcare provider to determine if Glyxambi is the right treatment for your individual health needs.\u003c\/p\u003e\r\n\u003cp\u003e\u003cem\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before starting or modifying any treatment regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"Magento","offers":[{"title":"Default Title","offer_id":49209693667574,"sku":"Glyxambi (Empagliflozin and Linagliptin) 25\/5mg 30 Tablets","price":85.2,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/1855\/0006\/files\/glyxambi-25-5-fixed-dose-combination-of-empagliflozin-tablets.jpg?v=1760859185"}],"url":"https:\/\/chemistway.com\/collections\/glyxambi.oembed","provider":"Chemistway","version":"1.0","type":"link"}